Simpson Reps KKR In $2.4B Pfizer Capsule Unit Buy
Asset manager Kohlberg Kravis Roberts & Co. LP said Monday it would buy Pfizer Inc.'s Capsugel drug delivery unit for $2.4 billion in cash as the pharmaceuticals behemoth conducts a review...To view the full article, register now.
Already a subscriber? Click here to view full article